OncClubAll Oncology NewsPipeline Report
InsightsMedical World NewsOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsThe Talk
Conference CoverageConference Listing
Giants of Cancer CarePER EventsScientific InterchangesState of the Science Summit / IPCWebinars
Partners
Oncology Live®Oncology FellowsSupplements And Featured PublicationsAll Publications
CME/CE
Interactive ToolsLearning ModulesPresentationsSponsored
Biomarker Consortium
Print SubscriptioneNewsletter
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
Spotlight -
  • 2024 nominations are open for Giants of Cancer Care®
  • In-person and virtual events just for HCPs
  • REGISTER TODAY to explore data on a novel second-generation BTK inhibitor for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
  • Share your views with OncChats
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
    • Partners
    • CME/CE
    • Biomarker Consortium
Advertisement

Considerations in the Management of Adult ITP

home / peer-exchange / adult-itp-management
Advertisement
Understanding the Pathophysiology of ITP

EP. 1: Understanding the Pathophysiology of ITP

January 15th 2018
Diagnosing Idiopathic Thrombocytopenia Purpura

EP. 2: Diagnosing Idiopathic Thrombocytopenia Purpura

January 15th 2018
Counseling Patients on Goals of Therapy in ITP

EP. 3: Counseling Patients on Goals of Therapy in ITP

January 15th 2018
Initiating Therapy in ITP

EP. 4: Initiating Therapy in ITP

January 15th 2018
Upfront Use of Corticosteroids in ITP

EP. 5: Upfront Use of Corticosteroids in ITP

January 15th 2018
Aggressive Treatment for Managing ITP

EP. 6: Aggressive Treatment for Managing ITP

January 15th 2018
Advertisement
Clinical Management of Corticosteroids in ITP

EP. 7: Clinical Management of Corticosteroids in ITP

January 15th 2018
Treatment Guidelines for Relapsed/Refractory ITP

EP. 8: Treatment Guidelines for Relapsed/Refractory ITP

January 15th 2018
TPO Receptor Agonists in ITP

EP. 9: TPO Receptor Agonists in ITP

January 15th 2018
TPO Receptor Agonists: Treatment Considerations

EP. 10: TPO Receptor Agonists: Treatment Considerations

January 15th 2018
Immunosuppressive Therapy in ITP

EP. 11: Immunosuppressive Therapy in ITP

January 15th 2018
Splenectomy Versus Other Therapy in ITP

EP. 12: Splenectomy Versus Other Therapy in ITP

January 15th 2018
Advertisement
Potential Role of Syk Inhibitors in ITP

EP. 13: Potential Role of Syk Inhibitors in ITP

January 15th 2018
Considerations for Treating ITP in the Future

EP. 14: Considerations for Treating ITP in the Future

January 15th 2018

Latest Conference Coverage

Adding Navitoclax to Ruxolitinib Doubles Spleen Volume Reductions for Myelofibrosis

MRD Positivity Correlates With Allogeneic Transplant Benefits in NPM1-Mutated AML

Orca-T Shows High Survival Rates in Intermediate-/High-Risk Myelodysplastic Syndrome

Orca-T Demonstrates Feasibility in Older Patients With Hematologic Malignancies

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777
© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact